Alkermes ALKS
NASDAQ ALKS
$45.40 -0.09 (-0.20%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alkermes (ALKS) Deferred Taxes (2011 - 2026)

Alkermes' (ALKS) quarterly Deferred Taxes came in at $9.1 million in Q2 2026, up 367.21% year-over-year from $1.9 million in Q2 2025, and up 203.61% quarter-over-quarter from -$8.8 million in Q1 2026.

Analysis

Alkermes (ALKS) Deferred Taxes (2011 - 2026) Analysis & Trends

Alkermes (ALKS) has reported Deferred Taxes for 16 consecutive years, with $9.1 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Deferred Taxes rose 367.21% year-over-year to $9.1 million in Q2 2026; TTM through Jun 2026 was $28.3 million, a 58.14% increase from a year earlier, with the FY2024 full-year figure at $40.5 million, up 140.56% from the prior year.
  • Deferred Taxes was $9.1 million for Q2 2026 at Alkermes, up from -$8.8 million in the prior quarter.
  • Over five years, Deferred Taxes peaked at $31.4 million in Q3 2025 and troughed at -$52.5 million in Q4 2023.
  • A 5-year average of -$3.6 million and a median of -$2.0 million in 2023 frame the typical range for Deferred Taxes.
  • Across the five-year window, Deferred Taxes plunged 657.58% in 2022 and soared 803.42% in 2024, its largest moves.
  • Over 5 years, Deferred Taxes stood at $21.3 million in 2022, then sank by 346.81% to -$52.5 million in 2023, then surged by 115.63% to $8.2 million in 2024, then soared by 282.43% to $31.4 million in 2025, then tumbled by 71.0% to $9.1 million in 2026.
  • The last three Deferred Taxes figures came in at $9.1 million (Q2 2026), -$8.8 million (Q1 2026), and $31.4 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn -479.00 Mn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn -195.00 Mn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn -544.00 Mn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn -
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -1.32 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn -
7 Revolution Medicines 43.79 Bn 43.79 Bn - -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 115.62 Mn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 25.70 Mn
10 Alkermes 7.58 Bn 6.92 Bn 397.90 Mn 9.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.10 Mn
Mar 31, 2026 -8.79 Mn
Sep 30, 2025 31.39 Mn
Jun 30, 2025 -3.41 Mn
Mar 31, 2025 2.51 Mn
Dec 31, 2024 8.21 Mn
Sep 30, 2024 10.59 Mn
Jun 30, 2024 14.21 Mn
Mar 31, 2024 7.52 Mn
Dec 31, 2023 -52.52 Mn
Sep 30, 2023 -9.25 Mn
Jun 30, 2023 -2.02 Mn
Mar 31, 2023 -36.12 Mn
Dec 31, 2022 21.28 Mn
Sep 30, 2022 -13.26 Mn
Jun 30, 2022 -11.51 Mn
Mar 31, 2022 -29.30 Mn
Dec 31, 2021 3.07 Mn
Sep 30, 2021 -8.79 Mn
Jun 30, 2021 5.55 Mn